Anaxomics - Systems biology solutions
  • About Us
    • Company's Vision and Values
    • The Team
    • Partners & Customers
    • Contact Us
  • Clinical Development
    • Mechanisms of Action
    • Biomarker Discovery
    • Head to Head Study
    • Patient Stratification
    • Clinical Trial re-Analysis
    • Clinical Trial Design
    • Drug Repositioning
  • Products and Services
    • Discovery and Pre-clinical Development
    • Academic Research Centers
    • → Mechanisms of Action
    • → Target Discovery
    • → Off-target Discovery
    • → High Throughput Data
    • → Efficay/Safety Profile
    • → Biomarker Discovery
    • → Drug Repositioning
    • → Disease Target Discovery
    • Solutions for VCs and Investors
    • In-Out Licensing: Product valuation
    • Nutraceuticals and Cosmetics
  • Our Technology
    • Systems Biology
    • Therapeutic Performance Mapping System (TPMS)
    • Scientific Publications & Congress
    • White Papers
    • Our Brochures
  • Collaborative Research
    • Ongoing Research Projects
    • Finalized Research Projects
» Our Technology » Products & Services Brochures

Products & Services Brochures

pdf-icon16Biomarker Discovery [1.1 MB]

pdf-icon16Clinical Efficacy and Safety Profile [1.1 MB]

pdf-icon16Combination Therapies [1.1 MB]

pdf-icon16Anaxomics Consulting Services [1.0 MB]

pdf-icon16Disease-Oriented Repositioning [1.1 MB]

pdf-icon16Drug Repositioning [1.1 MB]

pdf-icon16Drug-to-target and Off-target Discovery [1.2 MB]

pdf-icon16Disease-Oriented Repositioning, Case Studies [2.1 MB]

pdf-icon16A Successful Example in Amyothropic Lateral Sclerosis – Drug combinations [1.8 MB]

pdf-icon16Drug Safety Assesment, Case Studies [1.7 MB]

pdf-icon16Hight-Throughput Data Analysis by System Biology [1.2 MB]

pdf-icon16Identification of Therapeutic Target [1.1 MB]

pdf-icon16Solutions for In/Out Licensing Activities [1.3 MB]

pdf-icon16Mechanism of Action Analysis [1.5 MB]

pdf-icon16Solutions for Venture Capital Funds and Investors [1.3 MB]

pdf-icon16Solutions for Capital Raising and Out-Licensing Activities [1.2 MB]


FOLLOW US

LinkedIn Twitter

Sello PYME INNOVADORA 18/11/2024
PYME INNOVADORA
Válido hasta el 18 de noviembre de 2024
escudo de MEIC 18/11/2024

ISO 9001 ISO 27001
Copyright © 2023 Anaxomics Biotech SL – Systems Biology Solutions | Legal Disclaimer | Privacy Policy | Information Security Policy | Quality Policy